Thrombocytosis in COVID-19 patients without myeloproliferative neoplasms is associated with better prognosis but higher rate of venous thromboembolism

Saved in:
Bibliographic Details
Published in:Blood cancer journal (New York) 2021-11, Vol.11 (11), p.189-189, Article 189
Main Authors: Lucijanic, Marko, Krecak, Ivan, Soric, Ena, Sedinic, Martina, Sabljic, Anica, Derek, Lovorka, Jaksic, Ozren, Kusec, Rajko
Format: Article
Language:English
Subjects:
631/250/255
692/499
692/699/1541
Aged
Aged, 80 and over
Biomedical and Life Sciences
Biomedicine
Blood Platelets - pathology
Blood Platelets - virology
Cancer Research
Correspondence
COVID-19 - complications
COVID-19 - transmission
COVID-19 - virology
Female
Hematology
Humans
Male
Middle Aged
Myeloproliferative Disorders - blood
Myeloproliferative Disorders - virology
Oncology
Prognosis
SARS-CoV-2 - isolation & purification
Thrombocytosis - complications
Thrombocytosis - pathology
Thrombocytosis - virology
Venous Thromboembolism - etiology
Venous Thromboembolism - pathology
Venous Thromboembolism - virology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:2044-5385
2044-5385
DOI:10.1038/s41408-021-00585-2